Sublingual and Oral B12

What does the evidence say about effectiveness?

The NIH describes evidence suggesting no difference in efficacy between oral and sublingual B12. That comparison does not eliminate individual differences in tolerance or the need for clinician-directed injections. For postoperative care, the amount taken and the response to treatment remain central. NIH B12 fact sheet — NIH Office of Dietary Supplements

Compare dose, ingredients, and convenience

Read the amount per tablet or serving and how often it is intended to be taken. Check whether your multivitamin already includes B12. A lozenge may suit someone who dislikes capsules, but its sweeteners or flavor may be unpleasant. A swallowed tablet may be simpler once your surgical team permits it.

Do not confuse the choice between cyanocobalamin and methylcobalamin with proof of a clinical advantage. A marketing term such as “active” does not establish better outcomes for your situation. Ask the clinician which formulation and dose they intend. Clinical overview — Endotext / NCBI Bookshelf

When the route needs reassessment

Persistent low results, unreliable intake, or neurological symptoms can change the plan. A clinician should decide whether additional tests or a non-oral route is needed. Do not keep substituting lozenges for prescribed injections without discussing it.

Bring the product label and previous blood results to follow-up. Confirm the recheck interval and whether the current amount is prevention or deficiency treatment. See B12 after surgery for the broader monitoring questions.